CLC Number:
| [1] 谢晶日,李艳丽,王静滨.慢性乙型病毒性肝炎中医治疗研究进展[J].中华中医药学刊,2010,28(6): 1128-1130. [2] 王见义,王灵台.慢性乙型肝炎中医证型的研究与思考[J].光明中医,2010(9): 1743-1744. [3] 徐慧.谌宁生主任医师治疗慢性乙型肝炎的经验介绍[J].中国民族民间医药杂志,2009(3): 160. [4] 陈超.试述毒邪学说在病毒性肝炎辨治中的应用[J].辽宁中医杂志,2011,38(11): 2184-2186. [5] 杨明博,刘君颖,赵文霞.中医对乙肝肝硬化病因病机的认识[J].辽宁中医药大学学报,2009(1): 64-65. [6] 任顺通.中医治疗乙肝五法[J].光明中医,2012,27(4): 788-789. [7] 何正显,信玉琼,陈明.大黄的化学成分,药理作用及其在临床急症中的应用[J].中国中医急症,2007,16(2): 227-228. [8] 湛韬.慢性乙肝肝胆湿热证Hsp70诱导缺陷的研究及清肝利湿汤干预[D].中南大学,2011. [9] 慈倩倩,李英霞,等.香附的本草考证[J].四川中医,2010,28(4): 50-51. [10]史毅军.辨证分型治疗法在慢性乙型肝炎中的应用分析[J].中医临床研究,2011,3(17): 68-69. [11]朱鹏.《临证指南医案》 附子应用规律分析[J].中医杂志,2011,52(5): 438-440. [12]郑婕.卢秉久教授治疗慢性乙型肝炎之经验总结[D].辽宁中医药大学,2011. |
| [1] | Yuchen FAN. Current progress on prevention of mother to child transmission of hepatitis B virus [J]. Journal of Shandong University (Health Sciences), 2021, 59(5): 46-51,67. |
| [2] | LIU Qiuxia, WANG Lei, LIU Feng, QU Yundong, YE Qian, QIAN Yu, ZHANG Yuan, ZHANG Lixin. Hypophosphatemia during long-term adefovir dipivoxil therapy in patients with hepatitis B virus infection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(7): 73-78. |
| [3] | QIAN Yu, QU Yundong, WANG Ziyu, LIU Feng, YE Qian, WANG Lei. Risk factors to influence renal function of patients with chronic hepatitis B virus infection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(1): 29-32. |
| [4] | LIU Tongyan1, ZHANG Longyue2, LI Yuerong3, SUN Jingli2, HAN Zenglu3, LI Zhiquan1, ZHANG Lixin1, WANG Lei1. Prospective cohort observation of patients with hepatitis B e antigen-positive chronic hepatitis B treated by Adefovir dipivoxil and Interferon-α [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(6): 72-78. |
| [5] | CAO Tong1, WANG Yiguo2. Effect of hepatitis C virus core protein on the apoptosis of human hepatocytes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 37-39. |
| [6] | FU Xiao-li， WANG Lei， LIU Feng. HBsAg quantitative value in different stages of hepatitis B virus infection and its correlations with serum HBV DNA and age [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(5): 94-98. |
| [7] | XU Hui1, WANG Yi-guo2, LIU Chang-hong2, LIU Qian2, DU Juan3. Expression of HBV and its effects on the transdifferentiation in HK-2 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(3): 15-20. |
| [8] |
L Jing-jing1,2， YAN Bing-yu2， CHEN Shi-yu3， XU Ai-qiang2， LIU Jia-ye2， FENG Yi2，GONG Xiao-hong4， CUI Fu-qiang4， LIANG Xiao-feng4， ZHANG Li2，.
Antibody response and the influencing factors after revaccination with three doses of hepatitis B vaccines among lowresponse adults [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(11): 126-. |
| [9] |
ZHANG Xiu-zhen, LIU Li, LIU Qian.
Relativity of serum leptin level and response to antiviral therapy in patients with chronic hepatitis B [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(9): 96-99. |
| [10] |
SUN Chao1,2, XIE Shuang-shuang2， XIAO Di2, LIU Caixia1,2, YU Jin-hong2, LIU Li2, LI Qiang2.
Risk factors of acute hepatitis B complicated with serious hyperbilirubinemia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 88-. |
| [11] | GAO Shu-chun, GENG Da-ying, CUI Lei, ZHANG Li-xin, ZHANG Qin-gang， CHEN Shi-jun. Influence of Telbivudine on serum IL-2 and IL-6 in chronic hepatitis B [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(8): 92-95. |
| [12] |
TAN lin, LI Sha-sha, GAO Xue-wu.
Effect of anti-virus combined with glucocorticoids and plasma exchange on patients with hepatitis B with tendency to Hepatargia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(3): 90-92. |
| [13] | HONG Sen1， WANG Yi-guo2， LIU Chang-hong2， ZHANG Peng-ju3， LIU Qian2. Expression of recombinant HBV in the NHMC cells and its influence on cell apoptosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(1): 34-. |
| [14] | CUI Hai-bin1, CUI Su-nan2, WANG Ming-ming2, ZHANG Xiu-zhen2, LIU Kui-hua2, GUO Nan1. Plasma osmotic pressure score in predicting prognosis of patients with hepatorenal syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(6): 103-106. |
| [15] | YANG Fang, WANG Lei. Telbivudine-resistant mutation in patients with chronic hepatitis B: a retrospective study of 15 cases [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2011, 49(4): 129-132. |
|
||
